History never repeats but often rhymes. So when it comes to the demise of bull markets, we can, to borrow the immortal line of Captain Renault in Casablanca, round up the usual suspects. Often, the factors below are found at the scene of the crime (the start of a bear market). None appears to be an imminent threat yet, but it pays to be on the lookout for these bear-market bellwethers.
SEE ALSO: 7 Cheap Stocks the Market Left Behind
1. Higher inflationSpiraling prices reduce consumer buying power, which accounts for some 70% of U.S. economic activity. Inflation also whittles the value of financial assets. Think back to the mid 1970s, when oil (and wheat) price shocks bumped consumer prices to double digits in 1974. Inflation vacuumed money out of financial assets and into gold, real estate and other hard assets, and Standard & Poor�� 500-stock index lost 48% of its value between January 1973 and October 1974. (All figures for bear-market declines exclude dividends.)
Top 5 Oil Service Stocks To Own For 2016: Nuveen Equity Premium Opportunity Fund (JSN)
Nuveen Equity Premium Opportunity Fund (the Fund) is a diversified, closed-end management investment company. The Fund primarily invests in a diversified equity portfolio that seeks to substantially replicate price movements of either the Standard & Poor's 500 Stock Index or a weighted average of the Standard & Poor's 500 Stock Index and the NASDAQ-100 Index and is designed to support the Funds' index option strategies. Nuveen Asset Management is the adviser of the Fund. The Adviser has engaged Gateway Investment Advisers, L.P. (Gateway/Sub-Adviser) as Sub-Adviser to provide discretionary investment advisory services.
The initial target weighting of the Fund's equity portfolio in seeking to replicate the weighted average price movements of the market indexes will be 75% of the Standard & Poor's 500 Stock Index and 25% of the NASDAQ-100 Index. Over time, these percentage weightings may vary as the result of relative changes in each index. The Fund intends to pursue its investment objectives by utilizing an index option strategy of selling index call options and buying index put options, each on the Standard & Poor's 500 Stock Index and the NASDAQ-100 Index.
The Fund's comparative benchmark performance is a blended return consisting of 75% of the return of the S&P 500 Index, and 25% of the return of the NASDAQ-100 Index, which includes 100 of the largest domestic and international non-financial companies listed on The NASDAQ Stock Market based on market capitalization. The NASDAQ-100 Index reflects companies across major industry groups, including computer hardware and software, telecommunications, retail/wholesale trade and biotechnology.
Advisors' Opinion:- [By Robert Hsu]
Here are four to consider:
PowerShares S&P 500 BuyWrite ETF (PBP), yielding 4.09%
Madison/Claymore Covered Call & Equity Strategy (MCN), yielding 8.94%
Nuveen Equity Premium Opportunity Fund (JSN), yielding 9.19%
BlackRock Enhanced Dividend Achievers (BDJ), yielding 7.39%
The yield on these funds is very attractive. Even more attractive is the fact that many buy-write funds actually are selling at a discount to their net asset value.
- [By Robert Hsu]
Name Type of Security� Recommendation� Kinder Morgan Energy Partners L.P. (NYSE: KMP) � MLP August 15, 2013� TeeKay LNG Partners L.P.� (NYSE: TGP) � MLP September 16, 2013� PowerShares S&P 500 BuyWrite Portfol ETF� (NYSE Arca: PBP)� Buy-Write ETF September 30, 2013� Madison Covered Call Equity Strtgy Fd (NYSE: MCN)� Buy-Write ETF September 30, 2013� Nuveen Equity Premium Opportunity Fund (NYSE: JSN)� Buy-Write ETF September 30, 2013� BlackRockEnhanced Dividend Achievers Tr (NYSE: BDJ)� Buy-Write ETF September 30, 2013� Vornado Realty Trust � (NYSE: VNO)� Real Estate
Investment
Trust September 26, 2013�Robert Hsu is the editor of Permanent Wealth Investor and a former hedge fund portfolio manager at Wall Street powerhouse Goldman Sachs. He retired from Goldman at age 31. He since has come out of retirement to establish and preside over his money management firm, Absolute Return Capital Advisors. His retirement experience has given him his current mission: helping investors like you achieve their goal of comfortable retirement through profitable income strategies.
Best Industrial Disributor Stocks For 2015: Aethlon Medical Inc (AEMD)
Aethlon Medical, Inc. (Aethlon), incorporated on April 17, 1991, is a developmental-stage company. The Company is focused on creating medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.
The Company's Aethlon ADAPT (Adaptive Dialysis-Like Affinity Platform Technology) system is a revenue-stage technology platform that provides the basis for a new class of devices that provide rapid, selective removal of disease promoting particles from the entire circulatory system. The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under the Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers.
The Aethlon Hemopurifier
The Company's Hemopurifier is a medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation. Under the feasibility study protocol, the Company will enroll ten end-stage renal disease (ESRD) patients who are infected with the Hepatitis C virus (HCV) to demonstrate the safety of Hemopurifier therapy. In addition to augmenting the early viral kinetic response to SOC, the Company's Hemopurifier provides a candidate solution for viral rebound patients who traditionally are forced to discontinue therapy at the point HCV establishes resistance to drug regimens. Additionally, the Company's Hemopurifier represents a therapeutic strategy to address the population of HCV-infected dialysis patients for which SOC and all-antiviral strategies may be contraindicated or not cleared.
In design, the Company's Hemopurifier consists of the affinity lectin Galanthus nivalis agglutinin (GNA) immobilized in the outer-capillary space of advanced plasma membrane technology. The design allows for extracorporeal therapeutic delivery to occur on standard CRRT and dialysis instruments alre! ady located in hospitals and clinics worldwide. The mechanism of the Hemopurifier to rapidly eliminate a broad-spectrum disease targets is based on GNA�� ability to selectively bind high mannose signatures that are abundant on the surface of cancer-secreted exosomes and glycoproteins that reside on the outer membrane of infectious viral pathogens. The Company has also established a compassionate-use treatment program at the Medanta Medicity Institute in India that provides treatment access to HCV-infected individuals.
The Company's Hemopurifier has also been discovered to capture tumor-secreted exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. In addition to treating HCV-infected individuals, the Company has conducted a single proof of principal treatment study related to the treatment of HIV. In the study, Hemopurifier therapy reduced viral load by 93% in an HIV-AIDS infected individual without the administration of antiviral drug therapy. The study protocol provided for 12 Hemopurifier treatments, each four hours in duration, that were administered over the course of one month. Researchers at a university have since discovered that the Hemopurifier is able to capture exosomes that transport NEF protein, which is known to suppress the immune response in HIV-infected individuals.
The Company has been assigned all rights and title to and interests in an invention and related worldwide patent rights for a method to treat cancer under an assignment agreement with the London Health Science Center Research, Inc. (LHSCRI) The agreement provides that the Company is responsible for paying certain patent application and filing costs as well as a 2% royalty on any future net sales. The Company has als! o exercis! ed an option to license a pending patent entitled, Method to Inhibit Proliferation and Growth of Metastases from The Trustees of Boston University. The license provides a development strategy for new cancer therapies by uniting drug agents that inhibit the spread of cancer-related metastases with filtration techniques already in the Aethlon Hemopurifier(R). The resulting devices would inhibit tumor growth by reducing the presence of circulating growth factors without interfering with surgical wound healing or the recovery of tissue injured by radiation therapy.
The Company competes with Asahi Kasei Kurary Medical.
Advisors' Opinion:- [By James E. Brumley]
Stocks as a whole haven't gotten the new year off on the best foot, but that's not to say every equity out there is in trouble. Indeed, some small cap stocks may actually be doing well - and poised to do well for a while - specifically because larger companies are seeing their stocks struggle. To that end, traders looking for a bullish bright spot to start the new year may want to take a closer look at Amedica Corporation (NASDAQ:AMDA), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), and Aethlon Medical, Inc. (OTCMKTS:AEMD).
Best Industrial Disributor Stocks For 2015: Japan Petroleum Exploration Co Ltd (JPTXF)
Japan Petroleum Exploration Co., Ltd. is a company principally involved in the energy business. The Company operates in four geological segments. The Japan segment involves in the production, purchase and sale of crude oil and natural gas in Japan, the contracting of drilling and refurbishment works, mud logging works, research works, geophysical exploration works, the provision of pipeline maintenance services and security guard services, the purchase and sale of petroleum products, the transportation of petroleum and natural gas products, as well as real estate management business. The North America segment involves in the exploration and development of crude oil and natural gas in North America. The Middle East segment involves in the development of crude oil and natural gas. The Others segment involves in the exploration, development and production of crude oil and natural gas in Southeast Asia. As of March 31, 2013, the Company had 26 subsidiaries and 17 associated companies. Advisors' Opinion:- [By WWW.MARKETWATCH.COM]
LOS ANGELES (MarketWatch) -- Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to 楼101.28 from 楼101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast's full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)
Best Industrial Disributor Stocks For 2015: Atlatsa Resources Corp (ATL)
Atlatsa Resources Corporation is engaged in mining, exploration and development of mineral deposits located in the Bushveld Igneous Complex (BIC), South Africa. The principal business activity is the mining and exploration of platinum group metals (PGM), through its mineral property interests. The Company�� subsidiaries include N1C Resources Incorporation, Anooraq Minera Mexicana, N2C Resources Incorporation, Plateau Resources Proprietary Limited, Bokoni Holdings Proprietary Limited, Bokoni Mines Proprietary Limited, Boikgantsho Proprietary Limited, Kwanda Proprietary Limited, Ga-Phasha Proprietary Limited, Middlepunt Hill Management Services (Proprietary) Limited and Lebowa Platinum Mine Limited. Advisors' Opinion:- [By Roberto Pedone]
Another stock that's starting to move within range of triggering a big breakout trade is Atlatsa Resources (ATL), which engages in the mining, exploration and development of platinum group metals properties located in the Bushveld Igneous Complex in South Africa. This stock has been on fire so far in 2013, with shares up a whopping 198%.
If you take a look at the chart for Atlatsa Resources, you'll notice that this stock has been uptrending strong for the last two months and change, with shares soaring higher from its low of 28 cents per share to its intraday high of 46 cents per share. During that uptrend, shares of ATL have been consistently making higher lows and higher highs, which is bullish technical price action. Shares of ATL have now started to take out some near-term overhead resistance levels at 43 cents to 44 cents per share. That move is quickly pushing shares of ATL within range of triggering another big breakout trade.
Market players should now look for long-biased trades in ATL if it manages to break out above its 52-week high at 50 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 170,178 shares. If that breakout hits soon, then ATL will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at 63 cents to 73 cents per share, or even 80 cents per share.
Traders can look to buy ATL off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of 39 cents per share, or near more support at 37 cents per share. One can also buy ATL off strength once it clears its 52-week high at 50 cents with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Industrial Disributor Stocks For 2015: ProShares Ultra Dow30 (DDM)
ProShares Ultra Dow30 (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones Industrial Average (DJIA). The DJIA is a price-weighted index maintained by editors of The Wall Street Journal. The Index includes 30 large-cap, blue-chip United States stocks, excluding utility and transportation companies. Components are selected through a discretionary process with no predetermined criteria except that components should be established United States companies. The DJIA is not limited to traditionally defined industrial stocks, instead, the Index serves as a measure of the entire United States market, covering such diverse industries as financial services, technology, retail, entertainment and consumer goods. The Fund takes positions in securities and/or financial instruments that, in combination, should have similar daily return characteristics as 200% of the daily return of the Index. Its investment advisor is ProShare Advisors LLC. Advisors' Opinion:- [By Victor Selva]
In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.
- [By Damian Illia]
In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.
- [By Damian Illia]
In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.
- [By Victor Selva]
In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.
Best Industrial Disributor Stocks For 2015: SurModics Inc.(SRDX)
SurModics, Inc. provides drug delivery and surface modification technologies to the healthcare industry. The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, and urology markets. It also provides a range of drug delivery technologies for injectable therapeutics, including microparticles, nanoparticles, and implants addressing a range of clinical applications, such as ophthalmology, oncology, dermatology, and neurology. In addition, the company provides in vitro diagnostic component products and technologies comprising microarray slide technologies, protein stabilization reagents, substrates, polymers and reagent chemicals, and antigens for diagnostic test kits and biomedical research applications. SurModics, Inc. market s its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SurModics (Nasdaq: SRDX ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SurModics (Nasdaq: SRDX ) , whose recent revenue and earnings are plotted below.
No comments:
Post a Comment